Season 4: Episode 6: Huntington's Disease

What if scientists could stop a neurological disease from progressing—not just manage its symptoms?

That’s the question at the heart of this episode of Tumor Minutes. 🧠

Huntington’s disease is a genetic neurodegenerative disorder caused by a mutation in the HTT gene. It can affect movement, cognition, mood, and behavior, and for decades, treatment has focused primarily on managing symptoms rather than stopping the disease itself.

But recently, researchers achieved something remarkable. A gene therapy called AMT-130 has shown evidence of substantially slowing the progression of Huntington’s disease. We’re breaking down how it works, why surgeons have to deliver it directly into the brain, what researchers found in clinical trials, and why scientists are calling this a major turning point in Huntington’s research.

We’ll also look at the next generation of treatments, including stem-cell therapy and gene-editing approaches, and ask the biggest question of all:

Could we eventually stop Huntington’s disease before it causes significant damage?

No cure just yet—but for the first time, the future looks a little different.